UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Schroder Investment Management Group

Schroder Investment Management Group reduced its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 2.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,003,762 shares of the healthcare conglomerate's stock after selling 56,468 shares during the quarter. UnitedHealth Group comprises about 1.0% of Schroder Investment Management Group's portfolio, making the stock its 15th largest position. Schroder Investment Management Group owned about 0.22% of UnitedHealth Group worth $1,013,623,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in UNH. NewSquare Capital LLC acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $25,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the 4th quarter worth approximately $30,000. Promus Capital LLC bought a new position in shares of UnitedHealth Group during the fourth quarter valued at $32,000. Pillar Financial Advisors LLC acquired a new stake in UnitedHealth Group in the fourth quarter valued at $40,000. Finally, DecisionPoint Financial LLC grew its position in shares of UnitedHealth Group by 155.0% in the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate's stock valued at $52,000 after buying an additional 62 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company's stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at this link. Company insiders own 0.33% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several analysts recently commented on the company. Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Oppenheimer upped their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. Truist Financial lowered their target price on UnitedHealth Group from $625.00 to $610.00 and set a "buy" rating for the company in a report on Monday, January 6th. StockNews.com raised UnitedHealth Group from a "hold" rating to a "buy" rating in a report on Thursday, January 23rd. Finally, KeyCorp reissued an "overweight" rating and issued a $650.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Buy" and an average price target of $629.32.

UnitedHealth Group Trading Up 1.6 %

UNH traded up $8.44 during trading hours on Monday, reaching $524.48. The company's stock had a trading volume of 5,236,968 shares, compared to its average volume of 4,272,844. The stock has a market cap of $479.75 billion, a PE ratio of 33.84, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The business's 50-day moving average is $508.81 and its 200-day moving average is $543.92. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the company posted $5.83 earnings per share. The business's revenue for the quarter was up 6.8% on a year-over-year basis. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio (DPR) is 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.